Tadross joins Duke Neurosurgery faculty
Michael Tadross, MD, PhD, joined the department of Neurosurgery as an assistant
NIH grant renewal advances MR fingerprinting in epilepsy
A $3.2 million, five-year R01 renewal grant from the National Institutes of Health will further advance the work being done by researchers from Duke Neurosurgery and Cleveland Clinic in the clinical application of magnetic resonance fingerprinting (MRF) in epilepsy.
Celebrating 10 years of Duke Neurosurgery
Duke Neurosurgery became a full department in the Duke School of Medicine in 2015, having previously been a division in the Department of Surgery.
Foushee reintroduces Brain Spine Metastasis Awareness Month resolution
Rep. Valerie Foushee (NC-04) Monday reintroduced a resolution designating June as Brain and Spine Metastasis Awareness Month.
Raghavan Wins 2025 Snyderman Award
Duke Neurosurgery resident Alankrita Raghavan, MD, has been named the 2025 Snyderman Award winner for her project, “The Surgical Coaching Program: Developing a One-on-One Technical Curriculum for Junior Neurosurgical Residents.”
South Carolina man is "like a new person" after brain metastasis treatment
Brian FitzGerald of South Carolina spent the summer of 2024 looking for answers.
Learning the language of the brain
Nanthia Suthana, PhD, studies the neural mechanisms of cognition and behavior. She is especially interested in the complex processes that drive memory and emotion, and in developing therapies using neurostimulation to treat disorders that involve those processes. One such disorder is Alzheimer’s disease, which robs people of their memories. The flip side of that is PTSD, in which many patients are besieged by memories they don’t want.
Kellogg joins the Department of Neurosurgery
Robert Kellogg, MD, has joined the Duke Department of Neurosurgery in the Pediatric Neurosurgery Division. He comes to Duke from University of Pittsburgh, where he was an assistant professor for the past five years.
Duke neurosurgeons honored at AANS annual meeting
Two Duke neurosurgeons were honored at the 2025 annual meeting of the American Association of Neurological Surgeons in Boston.
Therapy combination carries risk for patients with brain metastases
Therapies that unleash the immune system to fight tumors have greatly extended the lives of people with many types of cancer.
But there are reports that patients with melanoma and lung cancer whose disease has spread to the brain may experience serious inflammatory reactions after receiving immunotherapy drugs concurrently with radiation.
In a study appearing April 9 in JAMA Network Open, researchers at the Duke Center for Brain and Spine Metastasis report a nearly two-fold increase in the risk of symptomatic brain inflammation, termed radiation necrosis, among patients with brain metastases receiving the immunotherapies within four weeks of a form of targeted radiation therapy called radiosurgery.